Qatar Business Standard

  • Home
  • Contact Us
Monday, August 4, 2025
You are here: Home » Archives for NASDAQ

Nanox.ARC Imaging System Receives CE Mark, Expanding Medical Imaging Offering in European Market

on February 25, 2025

  • CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S.
  • New clinical data supporting use of Nanox.ARC to [...] Read more »

Society for Clinical Research Sites (SCRS) e Fortrea Fazem Parceria para Promover a Colaboração na Pesquisa Clínica

on February 20, 2025

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — A Society for Clinical Research Sites (SCRS) e a Fortrea (Nasdaq: FTRE), uma organização líder global de pesquisa por contrato (CRO), tem o prazer de anunciar o [...] Read more »

La Society for Clinical Research Sites (SCRS) et Fortrea s’associent pour promouvoir la collaboration dans le domaine de la recherche clinique

on February 20, 2025

DURHAM, N.C., 20 févr. 2025 (GLOBE NEWSWIRE) — La Society for Clinical Research Sites (SCRS) et Fortrea (Nasdaq : FTRE), l’une des principales organisations de recherche contractuelle (ORC) à [...] Read more »

Society for Clinical Research Sites (SCRS) und Fortrea gehen eine Partnerschaft zur Förderung der Zusammenarbeit in der klinischen Forschung ein

on February 20, 2025

DURHAM, North Carolina, Feb. 20, 2025 (GLOBE NEWSWIRE) — Die Society for Clinical Research Sites (SCRS) und Fortrea (Nasdaq: FTRE), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization, [...] Read more »

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

on February 20, 2025

DURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) — The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to announce Fortrea’s [...] Read more »

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

on February 19, 2025

JERUSALEM , Feb. 19, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies in tablet [...] Read more »

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

on February 19, 2025

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab [...] Read more »

Trident et le ministère des Postes, des Télécommunications et des Technologies numériques de la République démocratique du Congo signent un accord pour la mise en œuvre du Système national d’identité numérique

on February 12, 2025

SINGAPOUR, 12 févr. 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (« Trident » ou la « Société », NASDAQ : TDTH), un catalyseur majeur de la [...] Read more »

Trident and the Ministry of Posts, Telecommunications, and Digital Technology of the Democratic Republic of the Congo Sign an Agreement for the Implementation of the National Digital Identity System

on February 12, 2025

SINGAPORE, Feb. 12, 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and [...] Read more »

Value of AI, Cloud Solutions Reign in Cellebrite’s 2025 Annual Industry Trends Survey

on February 11, 2025

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today [...] Read more »

Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations

on February 6, 2025

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) — Read more »

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

on February 5, 2025

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD–19 x FcγRIIb inhibitor of B cell function–

–Topline results from Phase 2 Trial in [...] Read more »

Lantronix Lança LM4, Nova Plataforma Out-of-Band Management Alimentada por IA na Cisco Live

on February 5, 2025

IRVINE, Califórnia, Feb. 05, 2025 (GLOBE NEWSWIRE) — A Read more »

Lantronix stellt auf der Cisco Live erstmals die neue LM4-Out-of-Band-Management-Plattform mit KI-Unterstützung vor

on February 5, 2025

IRVINE, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) — Read more »

Lantronix présentera sa nouvelle plateforme de gestion hors bande LM4 alimentée par l’IA au salon Cisco Live

on February 5, 2025

IRVINE, Californie, 05 févr. 2025 (GLOBE NEWSWIRE) — Read more »

« Previous Page
Next Page »
k-Detail-of-colorful-group-of-vi-26488397-2

Automotive

Telecom

Telecom

Chemicals

Chemicals

Government

Government

RSS Unknown Feed

Arabic

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • POL: All Chinese ports (ShenZhen/ShangHai...)

  • Acapture

  • شركة أرو إليكترونكس تعتزم تقديم أدوات نت سكاوت المتنقلة للتحليل وتشخيص الأعطال وإصلاحها للمساعدة في تحقيق أقصى حد لأداء شبكة الواي فاي (WiFi) في الشرق الأوسط


<< المزيد

  Qatari Rial Exchange Rate

 

Calendar

August 2025
M T W T F S S
« Jul    
 123
45678910
11121314151617
18192021222324
25262728293031

Admin Login

Copyright © 2025 Qatar Business Standard